Lennon VA; Wingerchuk DM; Kryzer TJ; Pittock SJ; Lucchinetti CF; Fujihara K; Nakashima I; Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.Lancet. 2004; 364(9451):2106-2112.
Weinstock-Guttman B; Ramanathan M; Lincoff N; Napoli SQ; Sharma J; Feichter J; Bakshi R. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).Arch Neurol. 2006; 63(7):957-63.
Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006; 63(3):390-6.
Correale J; Fiol . Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology. 2004; 63(12):2363-70
Pittock SJ; Weinshenker BG; Lucchinetti CF; Wingerchuk DM; Corboy JR; Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.Arch Neurol. 2006; 63(7):964-8 .
Watanabe S; Nakashima I; Misu T; Miyazawa I; Shiga Y; Fujihara K; Itoyama Y. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.Mult Scler. 2007; 13(1):128-32.
Wingerchuk DM; Pittock SJ; Lucchinetti CF; Lennon VA; Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica.Neurology. 2007; 68(8):603-5
Sunday, April 8, 2007
Subscribe to:
Post Comments (Atom)
4 comments:
Hello, just found your Blog. Thought you might like to check my Devic's support group site.
http://groups.google.com/group/Devics-support
hi there i am gayle and i run the worldwide devic's support group, found you on a google search and thought i would let you know we have a website all about devic's at www.devic.org.uk we are collecting a worldwide survey of people affected by NMO and would like anybody out there affected by devic's to fill in our survey online which will help with future research and study of this rare condition thanks for your time
love gayle
xxxxx
I will add your links so they will remain visible as we add posts
thanks neurodoc! lovin your work
gayle
xxxxxxxxxxxxxx
Post a Comment